[{"Assets_0_Q2_USD":543886000.0,"CommonStockSharesOutstanding_0_Q2_shares":53829000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-94551000.0,"NetIncomeLoss_2_Q2_USD":-131606000.0,"NetIncomeLoss_1_Q2_USD":-66287000.0,"StockholdersEquity_0_Q2_USD":241127000.0,"Ticker":"TBPH","CIK":"1583107","name":"THERAVANCE BIOPHARMA, INC.","OfficialName":"Theravance Biopharma Inc. Ordinary Shares","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"688048421.0","Country":"Cayman Islands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170809"}]